Related Experiment Video

Updated: Jul 16, 2026

Visualization of Amyloid β Deposits in the Human Brain with Matrix-assisted Laser Desorption/Ionization Imaging Mass Spectrometry
09:31

Visualization of Amyloid β Deposits in the Human Brain with Matrix-assisted Laser Desorption/Ionization Imaging Mass Spectrometry

Published on: March 7, 2019

Clinical phenotypes of Cerebral Amyloid Angiopathy

Luís F Maia1, Ian R A Mackenzie, Howard H Feldman

  • 1Department of Neurology, Hospital Geral Santo António, Porto, Portugal.

Journal of the Neurological Sciences
|March 8, 2007
PubMed

Insights

Cerebral Amyloid Angiopathy (CAA) involves amyloid protein buildup in brain blood vessels, leading to diverse neurological symptoms. This review details its clinical, pathological, and imaging features.

Area of Science:

  • Neurology
  • Pathology
  • Neuroimaging

Background:

  • Cerebral Amyloid Angiopathy (CAA) is characterized by amyloid protein deposition in cerebral blood vessels.
  • This condition, a CNS vasculopathy, presents with a range of clinical manifestations.
  • CAA is increasingly linked to cognitive impairment, dementia, and transient neurological events.

Purpose of the Study:

  • To provide a comprehensive overview of Cerebral Amyloid Angiopathy.
  • To review the clinical, pathological, and neuroimaging aspects of CAA.

Main Methods:

  • Literature review of clinical studies on CAA.
  • Analysis of pathological findings in CAA.
  • Examination of neuroimaging techniques for CAA diagnosis.

Main Results:

  • CAA affects both leptomeningeal and cortical cerebral blood vessels.
  • Clinical presentations include ischemic and hemorrhagic events.
  • Cognitive decline and transient neurological symptoms are recognized features of CAA.

Conclusions:

  • Cerebral Amyloid Angiopathy is a significant cerebrovascular pathology.
  • Understanding its multifaceted aspects is crucial for diagnosis and management.
  • Further research into CAA's clinical spectrum and imaging is warranted.

More Related Videos

Longitudinal In Vivo Imaging of the Cerebrovasculature: Relevance to CNS Diseases07:47

Longitudinal In Vivo Imaging of the Cerebrovasculature: Relevance to CNS Diseases

Published on: December 6, 2016

A Mouse Model of Hemorrhagic Transformation Induced by Acute Hyperglycemia Combined with Transient Focal Ischemia09:35

A Mouse Model of Hemorrhagic Transformation Induced by Acute Hyperglycemia Combined with Transient Focal Ischemia

Published on: November 15, 2024

Related Concept Videos

Cerebral Edema ll: Pathophysiology01:22

Cerebral Edema ll: Pathophysiology

Vasogenic edema is a major form of cerebral edema characterized by abnormal accumulation of fluid in the brain’s extracellular space due to disruption of the blood–brain barrier (BBB). The BBB is a specialized structure composed of endothelial cells connected by tight junctions, supported by astrocytic endfeet and a basement membrane. Under normal conditions, it tightly regulates the movement of ions, proteins, and solutes between the bloodstream and brain parenchyma. When this barrier loses...
Dementia l: Introduction01:22

Dementia l: Introduction

Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
Hepatic Encephalopathy01:29

Hepatic Encephalopathy

DefinitionHepatic encephalopathy is a reversible neurologic syndrome that results from advanced liver dysfunction or portosystemic shunting. It leads to disturbances in cognition, behavior, and motor function due to the brain’s exposure to gut-derived toxins that the liver fails to detoxify.EtiologyThis condition develops either in the setting of acute fulminant hepatitis or progressively during chronic liver disease, such as cirrhosis and portal hypertension. Portosystemic shunting—including...
Cerebral Edema l: Introduction01:19

Cerebral Edema l: Introduction

Cerebral edema is a pathological increase in brain water content that disrupts intracranial pressure regulation and impairs neurological function. Because the cranial vault is rigid, even modest increases in tissue volume can compromise cerebral perfusion, distort neural structures, and initiate secondary injury. Cerebral edema develops through four principal mechanisms: vasogenic, cytotoxic, interstitial, and ionic.Vasogenic EdemaVasogenic edema arises from disruption of the blood–brain...
Alzheimer Disease ll: Pathophysiology01:23

Alzheimer Disease ll: Pathophysiology

Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
Alzheimer Disease l: Introduction01:29

Alzheimer Disease l: Introduction

Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...